Seer appoints Rachel Haurwitz, Ph.D. to its board; David Singer resigns

Seer, Inc.

Dr. Haurwitz, CEO of Caribou Biosciences, appointed to Seer board effective Nov. 8, 2021 as Class II director.
David Singer resigned as director effective Nov. 8; no dispute or disagreement with Seer.
Dr. Haurwitz receives standard non-employee director cash compensation of $40k/year plus initial option for 30,000 shares.
Deep Nishar replaces Singer on Audit Committee.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Singer

Director

SEER · Seer, Inc.

Effective: 2021-11-08
Filed: November 8, 2021, 6:59 PM ET

On November 4, 2021, David Singer notified the Board of his intent to resign as a director, effective as of November 8, 2021.

Appointed

Rachel Haurwitz

Director

SEER · Seer, Inc.

Effective: 2021-11-08
Filed: November 8, 2021, 6:59 PM ET

On November 7, 2021, Rachel Haurwitz, Ph.D. was appointed to the board of directors (the “Board”) of Seer, Inc. (the “Company”), effective as of November 8, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Singer resigned as Director at Seer, Inc..

Action: resigned
Role: Director

Exact text from the filing

On November 4, 2021, David Singer notified the Board of his intent to resign as a director, effective as of November 8, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Rachel Haurwitz was appointed as Director at Seer, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 7, 2021, Rachel Haurwitz, Ph.D. was appointed to the board of directors (the “Board”) of Seer, Inc. (the “Company”), effective as of November 8, 2021.

View on SEC.gov

Seer, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-21-022257

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.